UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 306

Sortiert nach

Pembrolizumab for locally advanced and recurrent/metastatic cutaneous squamous cell carcinoma (KEYNOTE-629 study): an open-label, nonrandomized, multicenter, phase II trial

Annals of oncology, 2021-10, Vol.32 (10), p.1276-1285

2021

Link zum Volltext

Verfügbarkeit prüfen

Aktueller Stand bei nichtmelanozytären Hauttumoren

Der Onkologe, 2021-06, Vol.27 (6), p.524-524

2021

Link zum Volltext

Verfügbarkeit prüfen

Histamine suppresses epidermal keratinocyte differentiation and impairs skin barrier function in a human skin model

Allergy (Copenhagen), 2013-01, Vol.68 (1), p.37-47

2013

Link zum Volltext

Verfügbarkeit prüfen

IgE blockade in the management of eosinophil-associated recalcitrant pruritus due to medical tumor therapy

Annals of oncology, 2021-06, Vol.32 (6), p.696-697

2021

Link zum Volltext

Verfügbarkeit prüfen

Long‐term efficacy and safety of sonidegib in patients with advanced basal cell carcinoma: 42‐month analysis of the phase II randomized, double‐blind BOLT study

British journal of dermatology (1951), 2020-06, Vol.182 (6), p.1369-1378

2020

Link zum Volltext

Verfügbarkeit prüfen

Corrigendum to ‘IgE blockade in the management of eosinophil-associated recalcitrant pruritus due to medical tumor therapy’: Annals of Oncology 2021; volume 32: 696-697

Annals of oncology, 2021-10, Vol.32 (10), p.1310-1310

2021

Link zum Volltext

Verfügbarkeit prüfen

Medical treatment of advanced cutaneous squamous‐cell carcinoma

Journal of the European Academy of Dermatology and Venereology, 2019-12, Vol.33 (S8), p.38-43

2019

Link zum Volltext

Verfügbarkeit prüfen

Sonidegib and vismodegib in the treatment of patients with locally advanced basal cell carcinoma: a joint expert opinion

Journal of the European Academy of Dermatology and Venereology, 2020-09, Vol.34 (9), p.1944-1956

2020

Link zum Volltext

Verfügbarkeit prüfen

The pattern and clinicopathological correlates of programmed death‐ligand 1 expression in cutaneous squamous cell carcinoma

British journal of dermatology (1951), 2017-05, Vol.176 (5), p.1354-1356

2017

Link zum Volltext

Verfügbarkeit prüfen

Long‐term efficacy and safety of sonidegib in patients with locally advanced and metastatic basal cell carcinoma: 30‐month analysis of the randomized phase 2 BOLT study

Journal of the European Academy of Dermatology and Venereology, 2018-03, Vol.32 (3), p.372-381

2018

Link zum Volltext

Verfügbarkeit prüfen

Radiosensitization by BRAF inhibitor therapy—mechanism and frequency of toxicity in melanoma patients

Annals of oncology, 2015-06, Vol.26 (6), p.1238-1244

2015

Link zum Volltext

Verfügbarkeit prüfen

Histamine H4 receptor knockout mice display reduced inflammation in a chronic model of atopic dermatitis

Allergy (Copenhagen), 2016-02, Vol.71 (2), p.189-197

2016

Link zum Volltext

Verfügbarkeit prüfen

Acral lentiginous melanoma: a skin cancer with unfavourable prognostic features. A study of the German central malignant melanoma registry (CMMR) in 2050 patients

British journal of dermatology (1951), 2018-02, Vol.178 (2), p.443-451

2018

Link zum Volltext

Verfügbarkeit prüfen

Erythema nodosum-like lesions during BRAF inhibitor therapy: Report on 16 new cases and review of the literature

Journal of the European Academy of Dermatology and Venereology, 2015-09, Vol.29 (9), p.1797-1806

2015

Link zum Volltext

Verfügbarkeit prüfen

Analysis of c-KIT expression and KIT gene mutation in human mucosal melanomas

British journal of cancer, 2008-12, Vol.99 (12), p.2065-2069

2008

Link zum Volltext

Verfügbarkeit prüfen

Human basophil chemotaxis and activation are regulated via the histamine H4 receptor

Allergy (Copenhagen), 2016-09, Vol.71 (9), p.1264-1273

2016

Link zum Volltext

Verfügbarkeit prüfen

Vorgehen bei kutanem Plattenepithelkarzinom

Der Onkologe, 2021-06, Vol.27 (6), p.579-586

2021

Link zum Volltext

Verfügbarkeit prüfen

Protective measures for patients with advanced cancer during the Sars-CoV-2 pandemic: Quo vadis?

Clinical & experimental metastasis, 2021-06, Vol.38 (3), p.257-261

2021

Link zum Volltext

Verfügbarkeit prüfen

Effectiveness, safety and utilization of vismodegib in locally advanced basal cell carcinoma under real‐world conditions in Germany – The non‐interventional study NIELS

Journal of the European Academy of Dermatology and Venereology, 2021-08, Vol.35 (8), p.1678-1685

2021

Link zum Volltext

Verfügbarkeit prüfen

Prospective assessment of a gene signature potentially predictive of clinical benefit in metastatic melanoma patients following MAGE-A3 immunotherapeutic (PREDICT)

Annals of oncology, 2016-10, Vol.27 (10), p.1947-1947

2016

Link zum Volltext

Verfügbarkeit prüfen

A randomized, controlled phase III trial of nab-Paclitaxel versus dacarbazine in chemotherapy-naïve patients with metastatic melanoma

Annals of oncology, 2015-11, Vol.26 (11), p.2267-2274

2015

Link zum Volltext

Verfügbarkeit prüfen

Corrigendum to ‘Pembrolizumab for locally advanced and recurrent/metastatic cutaneous squamous cell carcinoma (KEYNOTE-629 study): an open-label, nonrandomized, multicenter, phase II trial: [Annals of Oncology Volume 32, Issue 10, October 2021, Pages 1276-1285]

Annals of oncology, 2022-08, Vol.33 (8), p.853-853

2022

Link zum Volltext

Verfügbarkeit prüfen

GNAQ and GNA11 mutant nonuveal melanoma: a subtype distinct from both cutaneous and uveal melanoma

British journal of dermatology (1951), 2020-11, Vol.183 (5), p.928-939

2020

Link zum Volltext

Verfügbarkeit prüfen

Profiling of histamine H4 receptor agonists in native human monocytes

British journal of pharmacology, 2013-09, Vol.170 (1), p.136-143

2013

Link zum Volltext

Verfügbarkeit prüfen

Checkpoint inhibitor-induced bullous pemphigoid differs from spontaneous bullous pemphigoid

Journal of the European Academy of Dermatology and Venereology, 2024-02

2024

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 306

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(246)
Mit Volltextzugriff
(296)

Publikationsform

Sprache

Englisch
(247)
Deutsch
(60)
Japanisch
(26)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Pembrolizumab for locally advanced and recurrent/metastatic cutaneous squamous cell carcinoma (KEYNOTE-629 study): an open-label, nonrandomized, multicenter, phase II trial

Aktueller Stand bei nichtmelanozytären Hauttumoren

Histamine suppresses epidermal keratinocyte differentiation and impairs skin barrier function in a human skin model

IgE blockade in the management of eosinophil-associated recalcitrant pruritus due to medical tumor therapy

Long‐term efficacy and safety of sonidegib in patients with advanced basal cell carcinoma: 42‐month analysis of the phase II randomized, double‐blind BOLT study

Corrigendum to ‘IgE blockade in the management of eosinophil-associated recalcitrant pruritus due to medical tumor therapy’: Annals of Oncology 2021; volume 32: 696-697

Medical treatment of advanced cutaneous squamous‐cell carcinoma

Sonidegib and vismodegib in the treatment of patients with locally advanced basal cell carcinoma: a joint expert opinion

The pattern and clinicopathological correlates of programmed death‐ligand 1 expression in cutaneous squamous cell carcinoma

Long‐term efficacy and safety of sonidegib in patients with locally advanced and metastatic basal cell carcinoma: 30‐month analysis of the randomized phase 2 BOLT study

Radiosensitization by BRAF inhibitor therapy—mechanism and frequency of toxicity in melanoma patients

Histamine H4 receptor knockout mice display reduced inflammation in a chronic model of atopic dermatitis

Acral lentiginous melanoma: a skin cancer with unfavourable prognostic features. A study of the German central malignant melanoma registry (CMMR) in 2050 patients

Erythema nodosum-like lesions during BRAF inhibitor therapy: Report on 16 new cases and review of the literature

Analysis of c-KIT expression and KIT gene mutation in human mucosal melanomas

Human basophil chemotaxis and activation are regulated via the histamine H4 receptor

Vorgehen bei kutanem Plattenepithelkarzinom

Protective measures for patients with advanced cancer during the Sars-CoV-2 pandemic: Quo vadis?

Effectiveness, safety and utilization of vismodegib in locally advanced basal cell carcinoma under real‐world conditions in Germany – The non‐interventional study NIELS

Prospective assessment of a gene signature potentially predictive of clinical benefit in metastatic melanoma patients following MAGE-A3 immunotherapeutic (PREDICT)

A randomized, controlled phase III trial of nab-Paclitaxel versus dacarbazine in chemotherapy-naïve patients with metastatic melanoma

Corrigendum to ‘Pembrolizumab for locally advanced and recurrent/metastatic cutaneous squamous cell carcinoma (KEYNOTE-629 study): an open-label, nonrandomized, multicenter, phase II trial: [Annals of Oncology Volume 32, Issue 10, October 2021, Pages 1276-1285]

GNAQ and GNA11 mutant nonuveal melanoma: a subtype distinct from both cutaneous and uveal melanoma

Profiling of histamine H4 receptor agonists in native human monocytes

Checkpoint inhibitor-induced bullous pemphigoid differs from spontaneous bullous pemphigoid

Suchergebnisse filtern